Correlation Between Delivra Health and Medipharm Labs

Can any of the company-specific risk be diversified away by investing in both Delivra Health and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delivra Health and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Delivra Health Brands and Medipharm Labs Corp, you can compare the effects of market volatilities on Delivra Health and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delivra Health with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delivra Health and Medipharm Labs.

Diversification Opportunities for Delivra Health and Medipharm Labs

-0.12

Correlation Coefficient

Delivra Health  Medipharm Labs

Good diversification

The 3 months correlation between Delivra and Medipharm is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Delivra Health Brands and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Delivra Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delivra Health Brands are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Delivra Health i.e., Delivra Health and Medipharm Labs go up and down completely randomly.

Pair Corralation between Delivra Health and Medipharm Labs

Assuming the 90 days horizon Delivra Health Brands is expected to under-perform the Medipharm Labs. In addition to that, Delivra Health is 2.36 times more volatile than Medipharm Labs Corp. It trades about -0.01 of its total potential returns per unit of risk. Medipharm Labs Corp is currently generating about 0.03 per unit of volatility. If you would invest  4.80  in Medipharm Labs Corp on September 4, 2024 and sell it today you would earn a total of  0.19  from holding Medipharm Labs Corp or generate 3.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Delivra Health Brands  vs.  Medipharm Labs Corp

Delivra Health Brands

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Delivra Health Brands has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Delivra Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Medipharm Labs Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward indicators, Medipharm Labs may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Delivra Health and Medipharm Labs

The main advantage of trading using opposite Delivra Health and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delivra Health position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.

The idea behind Delivra Health Brands and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .